Jesús María Hernández‐Rivas

Research interests

Publications

• Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study

  The Lancet · 2023 · https://doi.org/10.1016/s0140-6736(22)02036-0

• Second Revision of the International Staging System (R2-ISS) for Overall Survival in Multiple Myeloma: A European Myeloma Network (EMN) Report Within the HARMONY Project

  Journal of Clinical Oncology · 2022 · https://doi.org/10.1200/jco.21.02614

• Non-coding recurrent mutations in chronic lymphocytic leukaemia

  Nature · 2015 · 10.1038/nature14666

• Treatment of High-Risk Philadelphia Chromosome–Negative Acute Lymphoblastic Leukemia in Adolescents and Adults According to Early Cytologic Response and Minimal Residual Disease After Consolidation Assessed by Flow Cytometry: Final Results of the PETHEMA ALL-AR-03 Trial

  Journal of Clinical Oncology · 2014 · https://doi.org/10.1200/jco.2013.52.2425

• Landscape of somatic mutations and clonal evolution in mantle cell lymphoma

  Proceedings of the National Academy of Sciences · 2013 · https://doi.org/10.1073/pnas.1314608110

• Exome sequencing reveals novel and recurrent mutations with clinical impact in blastic plasmacytoid dendritic cell neoplasm

  Leukemia · 2013 · https://doi.org/10.1038/leu.2013.283

• NOTCH1 mutations identify a genetic subgroup of chronic lymphocytic leukemia patients with high risk of transformation and poor outcome

  Leukemia · 2012 · https://doi.org/10.1038/leu.2012.357

• Analysis of the immune system of multiple myeloma patients achieving long-term disease control by multidimensional flow cytometry

  Haematologica · 2012 · 10.3324/haematol.2012.067272

• Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia

  Nature · 2011 · https://doi.org/10.1038/nature10113

• Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia

  Nature Genetics · 2011 · 10.1038/ng.1032

• Deregulation of microRNA expression in the different genetic subtypes of multiple myeloma and correlation with gene expression profiling

  Leukemia · 2010 · 10.1038/leu.2009.274

• Cytogenetic risk stratification in chronic myelomonocytic leukemia

  Haematologica · 2010 · https://doi.org/10.3324/haematol.2010.030957

• Clinical Utility of Microarray-Based Gene Expression Profiling in the Diagnosis and Subclassification of Leukemia: Report From the International Microarray Innovations in Leukemia Study Group

  Journal of Clinical Oncology · 2010 · 10.1200/jco.2009.23.4732

• Outcome after relapse of acute lymphoblastic leukemia in adult patients included in four consecutive risk-adapted trials by the PETHEMA Study Group

  Haematologica · 2010 · 10.3324/haematol.2009.014274

• Microarray-based classifiers and prognosis models identify subgroups with distinct clinical outcomes and high risk of AML transformation of myelodysplastic syndrome

  Blood · 2009 · 10.1182/blood-2008-10-187203

• An international standardization programme towards the application of gene expression profiling in routine leukaemia diagnostics: the Microarray Innovations in LEukemia study prephase

  British Journal of Haematology · 2008 · 10.1111/j.1365-2141.2008.07261.x

• Gene expression profiling of B lymphocytes and plasma cells from Waldenström's macroglobulinemia: comparison with expression patterns of the same cell counterparts from chronic lymphocytic leukemia, multiple myeloma and normal individuals

  Leukemia · 2007 · 10.1038/sj.leu.2404520

• Comparison of intensive chemotherapy, allogeneic or autologous stem cell transplantation as post-remission treatment for adult patients with high-risk acute lymphoblastic leukemia. Results of the PETHEMA ALL-93 trial.

  PubMed · 2005

• Genetics and Cytogenetics of Multiple Myeloma

  Cancer Research · 2004 · https://doi.org/10.1158/0008-5472.can-03-2876

• Immunophenotypic analysis of Waldenstrom's macroglobulinemia

  Seminars in Oncology · 2003 · 10.1053/sonc.2003.50074

• Progression to Large B-Cell Lymphoma in Splenic Marginal Zone Lymphoma

  The American Journal of Surgical Pathology · 2001 · https://doi.org/10.1097/00000478-200110000-00007

• Characterization of acute promyelocytic leukemia cases lacking the classic t(15;17): results of the European Working Party. Groupe Français de Cytogénétique Hématologique, Groupe de Français d'Hematologie Cellulaire, UK Cancer Cytogenetics Group and BIOMED 1 European Community-Concerted Action "Molecular Cytogenetic Diagnosis in Haematological Malignancies".

  PubMed · 2000 · 10.1182/blood.v96.4.1297

• Increased number of chromosomal imbalances and high-level DNA amplifications in mantle cell lymphoma are associated with blastoid variants.

  PubMed · 1999 · https://doi.org/10.1182/blood.v93.12.4365

• The Apoptosis Inhibitor Gene API2 and a Novel 18q Gene,MLT, Are Recurrently Rearranged in the t(11;18)(q21;q21) Associated With Mucosa-Associated Lymphoid Tissue Lymphomas

  Blood · 1999 · 10.1182/blood.v93.11.3601

• Prognostic value of immunophenotypic detection of minimal residual disease in acute lymphoblastic leukemia.

  Journal of Clinical Oncology · 1998 · 10.1200/jco.1998.16.12.3774

• Prognostic Value of Numerical Chromosome Aberrations in Multiple Myeloma: A FISH Analysis of 15 Different Chromosomes

  Blood · 1998 · 10.1182/blood.v91.9.3366

• Immunophenotypic characterization of plasma cells from monoclonal gammopathy of undetermined significance patients. Implications for the differential diagnosis between MGUS and multiple myeloma.

  PubMed · 1998

Current projects

No projects listed.